A detailed history of Harfst & Associates, Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Harfst & Associates, Inc. holds 6,933 shares of WST stock, worth $2.16 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
6,933
Previous 6,827 1.55%
Holding current value
$2.16 Million
Previous $2.7 Million 15.48%
% of portfolio
0.53%
Previous 0.64%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$314.68 - $395.94 $33,356 - $41,969
106 Added 1.55%
6,933 $2.28 Million
Q1 2024

Apr 22, 2024

SELL
$338.27 - $413.0 $51,755 - $63,189
-153 Reduced 2.19%
6,827 $2.7 Million
Q4 2023

Feb 07, 2024

SELL
$318.29 - $392.21 $52,517 - $64,714
-165 Reduced 2.31%
6,980 $2.46 Million
Q3 2023

Nov 07, 2023

SELL
$354.9 - $412.41 $4,258 - $4,948
-12 Reduced 0.17%
7,145 $2.68 Million
Q2 2023

Aug 07, 2023

BUY
$334.63 - $382.47 $21,750 - $24,860
65 Added 0.92%
7,157 $2.74 Million
Q1 2023

May 10, 2023

SELL
$232.5 - $346.47 $1,627 - $2,425
-7 Reduced 0.1%
7,092 $2.46 Million
Q4 2022

Feb 13, 2023

BUY
$209.34 - $261.61 $54,428 - $68,018
260 Added 3.8%
7,099 $1.67 Million
Q3 2022

Oct 27, 2022

BUY
$246.08 - $343.65 $141,988 - $198,286
577 Added 9.21%
6,839 $1.68 Million
Q2 2022

Jul 28, 2022

SELL
$280.61 - $420.45 $71,555 - $107,214
-255 Reduced 3.91%
6,262 $1.89 Million
Q1 2022

Apr 28, 2022

BUY
$357.49 - $445.92 $192,687 - $240,350
539 Added 9.02%
6,517 $2.68 Million
Q4 2021

Feb 07, 2022

BUY
$402.25 - $471.34 $121,479 - $142,344
302 Added 5.32%
5,978 $2.8 Million
Q3 2021

Oct 28, 2021

SELL
$363.01 - $468.47 $108,539 - $140,072
-299 Reduced 5.0%
5,676 $2.41 Million
Q2 2021

Aug 11, 2021

SELL
$284.77 - $363.2 $102,801 - $131,115
-361 Reduced 5.7%
5,975 $2.15 Million
Q1 2021

May 10, 2021

BUY
$257.29 - $307.53 $281,732 - $336,745
1,095 Added 20.89%
6,336 $1.79 Million
Q4 2020

Jan 25, 2021

BUY
$261.16 - $301.66 $98,196 - $113,424
376 Added 7.73%
5,241 $1.48 Million
Q3 2020

Nov 04, 2020

SELL
$224.99 - $288.02 $253,788 - $324,886
-1,128 Reduced 18.82%
4,865 $1.34 Million
Q2 2020

Aug 07, 2020

SELL
$149.8 - $227.17 $51,830 - $78,600
-346 Reduced 5.46%
5,993 $1.36 Million
Q1 2020

May 05, 2020

BUY
$128.96 - $174.76 $27,210 - $36,874
211 Added 3.44%
6,339 $965,000
Q4 2019

Feb 14, 2020

BUY
$137.6 - $151.21 $12,796 - $14,062
93 Added 1.54%
6,128 $921,000
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $5,827 - $7,200
48 Added 0.8%
6,035 $855,000
Q2 2019

Aug 14, 2019

BUY
$111.27 - $125.15 $37,943 - $42,676
341 Added 6.04%
5,987 $749,000
Q1 2019

May 01, 2019

BUY
$94.53 - $110.2 $83,375 - $97,196
882 Added 18.51%
5,646 $622,000
Q4 2018

Feb 06, 2019

BUY
$93.0 - $123.98 $37,479 - $49,963
403 Added 9.24%
4,764 $467,000
Q3 2018

Oct 31, 2018

BUY
$98.01 - $123.47 $15,093 - $19,014
154 Added 3.66%
4,361 $538,000
Q2 2018

Aug 10, 2018

BUY
$83.32 - $101.88 $6,248 - $7,641
75 Added 1.82%
4,207 $417,000
Q1 2018

May 07, 2018

BUY
$85.56 - $102.4 $16,513 - $19,763
193 Added 4.9%
4,132 $364,000
Q4 2017

Feb 09, 2018

BUY
$91.65 - $101.65 $12,097 - $13,417
132 Added 3.47%
3,939 $388,000
Q2 2017

Aug 11, 2017

BUY
N/A
3,807
3,807 $359,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.